Technology News and Research

RSS

New clot busting drug approved in UK

The National Institute for Clinical Excellence (Nice), UK, has approved a new drug which one study has suggested could reduce the risk of death from a second heart attack by 20 per cent. The drug is manufactured by AstraZeneca as Brilique. It works by maintaining cardiac blood flow and stopping new blood clots from forming.

1 Jul 2011

Roche introduces new real-time PCR system

With "Size: Reduced. Fun: Amplified.", Roche Applied Science launched its new real-time PCR system on June 27th, 2011. The small, silent, sleek LightCycler Nano Instrument supports state-of-the-art technology for fast PCR protocols featuring leading edge thermal resolution and reproducibility.

1 Jul 2011

KCI receives reimbursement status for V.A.C.Via Negative Pressure Wound Therapy System

Kinetic Concepts, Inc. today announced that its groundbreaking V.A.C.Via Negative Pressure Wound Therapy System has been granted reimbursement status and will be listed on the U.K. Drug Tariff beginning August 1, 2011.

30 Jun 2011

Exposure to mobile phone derived electromagnetic fields can influence learning processes

High frequency non-ionizing radiation, emitted by mobile phones, is redundantly matter of discussions. The effects of high frequency electromagnetic fields derived from mobile phones have been discussed since the 1950's.

30 Jun 2011

Lotus Tissue Repair to develop DEB protein replacement therapy with $26 million Series A financing

Lotus Tissue Repair, Inc. today announced the closing of a $26 million Series A financing led by Third Rock Ventures. Proceeds of the financing will be used to advance the company's proprietary recombinant collagen type VII (rC7) technology as the first and only protein replacement therapy in development for the treatment of dystrophic epidermolysis bullosa (DEB), an orphan disease that causes devastating skin blisters, morbidity and early mortality.

30 Jun 2011

Harvard University, UCB enter innovative research collaboration

UCB and Harvard University officially launched their innovative Research Alliance during a signing ceremony that took place in Boston last night in the presence of his Royal Highness Prince Philippe of Belgium.

30 Jun 2011

Positive final results from Medicago's H5N1 Avian Influenza VLP vaccine Phase II trial

Medicago Inc. a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive final results from a Phase II human clinical trial with its H5N1 Avian Influenza VLP vaccine candidate.

30 Jun 2011

San Francisco grabs the mantle of 'greenest' major city in the U.S.

San Francisco grabbed the mantle of "greenest" major city in the U.S. and Canada Green City Index, with New York, Seattle, Denver and Boston rounding out the top five U.S. cities.

30 Jun 2011

New technique can remove oil spill from soil

It is well known just how damaging oil can be to nature. It is also well known just how difficult it can be to clean up after a spill or contamination. Removing an oil spill or contamination from soil is hard and requires very different techniques to removing oil from water.

30 Jun 2011

Anabasis, Scil Proteins enter license deal for rhNGF to treat eye diseases

Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.

30 Jun 2011

New technology reduces stress of scheduling chemotherapy treatments

The stress of scheduling chemotherapy treatments has been substantially reduced by a new technology created and implemented by a team of researchers from the Sauder School of Business at the University of British Columbia and the BC Cancer Agency.

30 Jun 2011

UNC study uses optogenetics to tweak brain wiring responsible for drug addiction behaviors

Using a combination of genetic engineering and laser technology, researchers at the University of North Carolina at Chapel Hill have manipulated brain wiring responsible for reward-seeking behaviors, such as drug addiction.

30 Jun 2011

UIC health sciences library receives $8.9M contract to serve 10-state Midwest region

The national library network responsible for MEDLINE/PubMed and other Web-based health information services has awarded an $8.9 million contract to the Library of the Health Sciences at the University of Illinois at Chicago to serve as its Midwest regional library for another five years.

30 Jun 2011

Researchers develop way to uncover evolution of human cancer cells

A team of researchers led by scientists at the University of California, San Francisco has developed a way to uncover the evolution of human cancer cells, determining the order in which mutations emerge in them as they wend their way from a normal, healthy state into invasive, malignant masses.

30 Jun 2011

Innovation in contact lenses for children wins Donald Korb Award

Earl L. Smith III, O.D., dean of the College of Optometry at the University of Houston (UH), recently received an award for his work in slowing the progression of nearsightedness in children.

30 Jun 2011

Boston University, University of Utah Foundation and Allegro enter license agreement for molecular testing platform

Allegro Diagnostics today announced that the company has entered into an exclusive license agreement with Boston University and the University of Utah Foundation for intellectual property related to the company's molecular testing platform. This platform utilizes gene expression of normal epithelial cells in the respiratory tract to detect early signs of lung cancer.

30 Jun 2011

Hemova device can reduce risk of infection, clotting and vessel narrowing in dialysis patients

Johns Hopkins University graduate students have invented a device to reduce the risk of infection, clotting and narrowing of the blood vessels in patients who need blood-cleansing dialysis because of kidney failure.

30 Jun 2011

Genes in Tasmanian Devil give new hope to children with cancer

Cancer researchers have generated a genetic blueprint of the Tasmanian Devil genome, revealing cancer-associated genes that may answer important questions about adult and childhood cancer.

30 Jun 2011

COIN hosts ‘Risk vs. Reward: Financing Early-Stage, Emerging Technologies’ roundtable event

The Center of Innovation for Nanobiotechnology (COIN) has announced the upcoming NanoBio Executive Roundtable event to be hosted at The Hawthorne Inn in Winston-Salem, NC on July 14, 2011. This Roundtable will address a significant hurdle to nanobiotechnology development and commercialization—early-stage funding.

29 Jun 2011

China Health first quarter gross revenues increase 52% to $6.759 million

China Health Labs & Diagnostics Ltd. is pleased to announce the financial results for the first quarter ended March 31, 2011.

29 Jun 2011

Technology News and Research

New clot busting drug approved in UK

Roche introduces new real-time PCR system

KCI receives reimbursement status for V.A.C.Via Negative Pressure Wound Therapy System

Exposure to mobile phone derived electromagnetic fields can influence learning processes

Lotus Tissue Repair to develop DEB protein replacement therapy with $26 million Series A financing

Harvard University, UCB enter innovative research collaboration

Positive final results from Medicago's H5N1 Avian Influenza VLP vaccine Phase II trial

San Francisco grabs the mantle of 'greenest' major city in the U.S.

New technique can remove oil spill from soil

Anabasis, Scil Proteins enter license deal for rhNGF to treat eye diseases

New technology reduces stress of scheduling chemotherapy treatments

UNC study uses optogenetics to tweak brain wiring responsible for drug addiction behaviors

UIC health sciences library receives $8.9M contract to serve 10-state Midwest region

Researchers develop way to uncover evolution of human cancer cells

Innovation in contact lenses for children wins Donald Korb Award

Boston University, University of Utah Foundation and Allegro enter license agreement for molecular testing platform

Hemova device can reduce risk of infection, clotting and vessel narrowing in dialysis patients

Genes in Tasmanian Devil give new hope to children with cancer

COIN hosts ‘Risk vs. Reward: Financing Early-Stage, Emerging Technologies’ roundtable event

China Health first quarter gross revenues increase 52% to $6.759 million

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News